AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work

Support provided by an independent educational grant from Allergan, Astellas and Medtronic

Instructional Course Director(s)
Kathleen Kobashi, MD, FACS, FPMRS
Virginia Mason Medical Center

Instructional Course Faculty(s)
Sandip Vasavada, MD
Professor of Surgery/Urology
Cleveland Clinic Glickman Urological Institute and Lerner College of Medicine

David Ginsberg, MD
USC Institute of Urology

This course would aim to discuss all guidelines-approved 3rd line therapies for the treatment of overactive bladder (OAB). Case–based discussion will be used adjunctively to illustrate how best to select patients in varying clinical scenarios and how to optimally counsel a patient on each of the available modalities, including onabotulinumtoxinA injection of the bladder, tibial nerve stimulation, and sacral nerve stimulation (SNS). Emerging therapies in neuromodulation will also be introduced.